Robuta

https://www.newswire.com/news/new-gadolinium-free-mri-contrast-agent-advances-safer-patient-care-21737140
Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP-001
mri contrast agentpatient carenewgadoliniumfree